<DOC>
<DOCNO>EP-0618206</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Pharmaceutical compounds
</INVENTION-TITLE>
<CLASSIFICATIONS>A61P3700	A61K3135	A61P3500	A61K3147	A61P2900	A61P2900	C07D49100	C07D40504	C07D31100	A61P3500	A61K3135	C07D40904	C07D40900	C07D40700	C07D491052	A61K3147	A61K31352	C07D40500	C07D31192	A61P900	C07D40704	A61P910	A61P116	A61P3706	C07D49104	A61P100	A61K31352	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61P	A61K	A61P	A61K	A61P	A61P	C07D	C07D	C07D	A61P	A61K	C07D	C07D	C07D	C07D	A61K	A61K	C07D	C07D	A61P	C07D	A61P	A61P	A61P	C07D	A61P	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61P37	A61K31	A61P35	A61K31	A61P29	A61P29	C07D491	C07D405	C07D311	A61P35	A61K31	C07D409	C07D409	C07D407	C07D491	A61K31	A61K31	C07D405	C07D311	A61P9	C07D407	A61P9	A61P1	A61P37	C07D491	A61P1	A61K31	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The invention provides pharmaceutical compounds of the formula: 

in which A --- B is CH₂-CH₂ or CH=CH;
 

X is a pyridine or benzene ring;
 

when X is pyridine n is 0;
 

when X is benzene n is 0, 1 or 2 and when A --- B is CH₂-CH₂, R¹ is 
attached at any of the positions 7 to 10, and when A --- B is CH=CH, R¹ 

is attached at any of the positions 5 to 10;
 

each R¹ is halo, carboxy, trifluoromethyl, hydroxy, C₁₋₄ alkyl, C₁₋₄ 
alkoxy, C₁₋₄ alkylthio, hydroxy-C₁₋₄ alkyl, hydroxy-C₁₋₄ alkoxy, 

nitrogen-containing heterocyclyl, nitro, trifluoromethoxy, -COOR⁵ where 
R⁵ is an ester group, -COR⁶, -CONR⁶R⁷ or -NR⁶R⁷ where R⁶ and R⁷ are each 

hydrogen or C₁₋₄ alkyl;
 

R² is phenyl, naphthyl or heteroaryl selected from thienyl, pyridyl, 
benzothienyl, quinolinyl, benzofuranyl or benzimidazolyl, said phenyl,  

 
naphthyl and heteroaryl groups being optionally substituted, or R² is 

furanyl optionally substituted with C₁₋₄ alkyl;
 

R³ is nitrile, carboxy, -COOR⁸ where R⁸ is an ester group, -CONR⁹R¹⁰ 
where R⁹ and R¹⁰ are each hydrogen or C₁₋₄ alkyl, or -SO₂R¹¹ where R¹¹ is 

C₁₋₄ alkyl, optionally substituted phenyl or optionally substituted 
phenyl-C₁₋₄ alkyl; and

 
R⁴ is 1-pyrrolyl, 1-imidazolyl or 1-pyrazolyl, said 1-pyrrolyl, 

1-imidazolyl and 1-pyrazolyl being optionally substituted by one or two 
C₁₋₄ alkyl, carboxyl, hydroxy-C₁₋₄ alkyl or -CHO groups, or 1-(1,2,4-triazolyl), 

1-(1,3,4-triazolyl) or 2-(1,2,3-triazolyl), said triazolyl 
groups being optionally substituted by a C₁₋₄ alkyl or C₁₋₄ 

perfluoroalkyl group, or 1-tetrazolyl optionally substituted by C₁₋₄ 
alkyl;

 
and salts thereof. 
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<DESCRIPTION>
This invention relates to pharmaceutical compounds, their preparation 
and use. The present invention comprises compounds of the formula: 
 
in which 
A --- B is CH2-CH2 or CH=CH; X is a pyridine or benzene ring; when X is pyridine n is 0; when X is benzene n is 0, 1 or 2 and when A --- B is CH2-CH2, R1 is 
attached at any of the positions 7 to 10, and when A --- B is CH=CH, R1 
is attached at any of the positions 5 to 10; each R1 is halo, carboxy, trifluoromethyl, hydroxy, C1-4 alkyl, C1-4, 
alkoxy, C1-4 alkylthio, hydroxy-C1-4 alkyl, hydroxy-C1-4 alkoxy, 
nitrogen-containing heterocyclyl selected from 2-pyridyl, 3-pyridyl, 
4-pyridyl, 1-piperidino, 1-pyrrolidino and 4-morpholinyl, nitro, 
trifluoromethoxy, -COOR5 where 
R5 is an ester group, -COR6, -CONR6R7 or -NR6R7 where R6 and R7 are each 
hydrogen or C1-4 alkyl;  
 R2 is phenyl, naphthyl or heteroaryl selected from thienyl, pyridyl, 
benzothienyl, quinolinyl, benzofuranyl or benzimidazolyl, said phenyl, 
naphthyl and heteroaryl groups being optionally substituted with one 
or more substituents each selected from halo, 
trifluoromethyl, C1-4 alkoxy, hydroxy, nitro, C1-4 alkyl, C1-4 
alkylthio, hydroxy-C1-4 alkyl, hydroxy-C1-4 alkoxy, trifluoromethoxy, 
carboxy, -COOR12 where R12 is an ester group, -CONR13R14 or -NR13R14 
where R13 and R14 are each hydrogen or C1-4 alkyl, or R2 is furanyl 
optionally substituted wih C1-4 alkyl; R3 is nitrile, carboxy, -COOR8 where R8 is an ester group, -CONR9R10 
where R9 and R10 are each hydrogen or C1-4 alkyl, or -SO2R11 where R11 is 
C1-4 alkyl, optionally substituted phenyl or optionally substituted 
phenyl-C1-4 alkyl, said optionally substituted phenyl being 
optionally substituted with one or more substituents each selected 
from halo, trifluoromethyl, C1-4 alkoxy, hydroxy, nitro, C1-4 alkyl, 
C1-4 alkyltio, hydroxy-C1-4 alkyl, hydroxy-C1-4 alkoxy, 
trifluoromethoxy, carboxy, -COOR12 where R12 is an ester group, 
-CONR13R14 or -NR13R14 where R13 and R14 are each hydrogen or C1-4 
alkyl; and R4 is 1-pyrrolyl, 1-imidazolyl or 1-pyrazolyl, said 1-pyrrolyl, 
1-imidazolyl and 1-pyrazolyl being optionally substituted by one or two 
C1-4 alkyl, carboxyl, hydroxy-C1-4 alkyl or -CHO groups, or 1-(1,2,4-triazolyl), 
1-(1,3,4-triazolyl) or 2-(1,2,3-triazolyl), said triazolyl 
groups being optionally substituted by a C1-4 alkyl or C1-4 
perfluoroalkyl group, or 1-tetrazolyl optionally substituted by C1-4 
alkyl;  
and salts thereof. In the above formula (I), A --- B is CH2-CH2 or CH=CH, and compounds of 
the
</DESCRIPTION>
<CLAIMS>
A compound of the formula: 

 
in which 


A --- B is CH
2
-CH
2
 or CH=CH; 
X is a pyridine or benzene ring; 
when X is pyridine n is 0; 
when X is benzene n is 0, 1 or 2 and when A --- B is CH
2
-CH
2
, R
1
 
is attached at any of the positions 7 to 10, and when A --- B is 

CH=CH, R
1
 is attached at any of the positions 5 to 10; 
each R
1
 is halo, carboxy, trifluoromethyl, hydroxy, C
1-4
 alkyl, 
C
1-4
 alkoxy, C
1-4
 alkylthio, hydroxy-C
1-4
 alkyl, hydroxy-C
1-4
 
alkoxy, nitrogen-containing heterocyclyl selected from 

2-pyridyl, 3-pyridyl, 4-pyridyl, 1-piperidino, 1-pyrrolidino 
and 4-morpholinyl, nitro, trifluoromethoxy, 

-COOR
5
 where R
5
 is a C
1
-C
4
 alkyl group, -COR
6
, -CONR
6
R
7
 or -NR
6
R
7
 where 
R
6
 and R
7
 are each hydrogen or C
1-4
 alkyl; 
R
2
 is phenyl, naphthyl or heteroaryl selected from thienyl, 
pyridyl, benzothienyl, quinolinyl, benzofuranyl or benzimidazolyl, 

said phenyl, naphthyl and heteroaryl groups being optionally  
 

substituted with one or more substituents each selected from halo, 
trifluoromethyl, C
1-4
 alkoxy, hydroxy, nitro, C
1-4
 alkyl, C
1-4
 
alkylthio, hydroxy-C
1-4
 alkyl, hydroxy-C
1-4
 alkoxy, trifluoromethoxy, 
carboxy, -COOR
12
 where R
12
 is an ester group, -CONR
13
R
14
 or -NR
13
R
14
 
where R
13
 and R
14
 are each hydrogen or C
1-4
 alkyl, or R
2
 is furanyl 
optionally substituted with C
1-4
 alkyl; 
R
3
 is nitrile, carboxy, -COOR
8
 where R
8
 is a C
1
-C
4
 alkyl group, 
-CONR
9
R
10
 where R
9
 and R
10
 are each hydrogen or C
1-4
 alkyl, or 
-SO
2
R
11
 where R
11
 is C
1-4
 alkyl, optionally substituted phenyl or 
optionally substituted phenyl-C
1-4
 alkyl, said optionally 
substituted phenyl being optionally substituted with one or more 

substituents each selected from halo, trifluoromethyl, C
1-4
 alkoxy, 
hydroxy, nitro, C
1-4
 alkyl, C
1-4
 alkylthio, hydroxy-C
1-4
 alkyl, 
hydroxy-C
1-4
 alkoxy, trifluoromethoxy, carboxy, -COOR
12
 where R
12
 is 
an ester group, -CONR
13
R
14
 or -NR
13
R
14
 where R
13
 and R
14
 are each 
hydrogen or C
1-4
 alkyl; and 
R
4
 is 1-pyrrolyl, 1-imidazolyl or 1-pyrazolyl, said 1-pyrrolyl, 
1-imidazolyl and 1-pyrazolyl being optionally substituted by one 

or two C
1-4
 alkyl, carboxyl, hydroxy-C
1-4
 alkyl or -CHO groups, or 
1-(1,2,4-triazolyl), 1-(1,3,4-triazolyl) or 2-(1,2,3-triazolyl), 

said triazolyl groups being optionally substituted by a C
1-4
 alkyl 
or C
1-4
 perfluoroalkyl group, or 1-tetrazolyl optionally 
substituted by C
1-4
 alkyl; 
 
and salts th
ereof.  
 
A compound according to Claim 1 of the formula: 

 
in which 


n is 0, 1 or 2; 
A --- B is CH
2
-CH
2
 or CH=CH;  
 
R
1
 is attached at any of the positions 7 to 10 when A is CH
2
-CH
2
 
or at any of the positions 5 to 10 when A is CH=CH; and R
1
, R
2
, R
3
 
and R
4
 have the values defined in Claim 1; and salts thereof. 
A compound according to Claim 2 in which R
4
 is 1-pyrrolyl. 
A compound according to either of Claims 2 and 3 in which R
2
 is 
optionally substituted phenyl. 
A compound according to any of Claims 2 to 4 in which R
3
 is 
nitrile. 
A compound according to any of Claims 2 to 5 in which n is 0. 
A compound according to Claim 1 or a pharmaceutically acceptable 
salt thereof, for use as a pharmaceutical. 
A pharmaceutical formulation comprising a compound according to 
Claim 1 or a pharmaceutically acceptable salt thereof, together 

with a pharmaceutically acceptable carrier or diluent therefor. 
</CLAIMS>
</TEXT>
</DOC>
